Endobiliary Percutaneous Cryobiopsy in Malignant Biliary Obstruction
BICRYOB
1 other identifier
interventional
20
1 country
1
Brief Summary
The rationale of the study is to explore the safety and efficacy of percutaneously performed endobiliary cryobiopsy in patiens with histologically unverified biliary stenosis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2023
CompletedFirst Submitted
Initial submission to the registry
September 11, 2023
CompletedFirst Posted
Study publicly available on registry
September 21, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedSeptember 21, 2023
September 1, 2023
1.2 years
September 11, 2023
September 19, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Sensitivity of biopsy sampling to detect malignancy
Comparison of sensitivity of endobiliary cryobiopsy and forceps biopsy for detection of malignancy.
up to month 12 or death of the patient
Quality of samples collected by endobiliary cryobiopsy and forceps biopsy - weight
Comparison of weight (in milligrams) of samples collected by endobiliary cryopsy and forceps biopsy. Each sample will be weighed separately and one measurement value will be recorded for each sample.
up to month 12 or death of the patient
Quality of samples collected by endobiliary cryobiopsy and forceps biopsy - size
Comparison of the size weight (in millimeters) of samples collected by endobiliary cryopsy and forceps biopsy. Each sample will be weighed in two dimensions on slide.
up to month 12 or death of the patient
Study Arms (2)
Cryobiopsy
EXPERIMENTALIn randomised patients in experimental arm was initially performed cryobiopsy (3 samples) and cosequently forceps biopsy (6 samples) with 5.2F or 7.5F forceps. Both sampling techniques were performed during one procedure of percutaneous transhepatic drainage under fluoroscopic control.
Forceps biopsy
ACTIVE COMPARATORIn randomised patients in control arm was initially performed forceps biopsy (6 samples) with 5.2F or 7.5F forceps and cosequently cryobiopsy (3 samples). Both sampling techniques were performed during one procedure of percutaneous transhepatic drainage under fluoroscopic control.
Interventions
Comparison of endobiliary forceps biopsy and cryobiopsy of biliary stenosis during percutaneous transhepatic drainage.
Eligibility Criteria
You may qualify if:
- biliary stenosis of unknown etiology
- unsuccessful or unfeasable ERCP
- indicated percutaneous transhepatic drainage
You may not qualify if:
- histologically verified biliary stenosis
- INR ≥ 1,5
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Brno University Hospital
Brno, 62500, Czechia
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Masking Details
- Randomization was performed by the Institute of Biostatistics and Analysis of Masaryk University Brno.
- Purpose
- DIAGNOSTIC
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Tomáš Andrašina, MD, PhD; Assistant professor, Head of Non-vascular interventions and Computed Tomography of the Department of Radiology and Nuclear Medicine
Study Record Dates
First Submitted
September 11, 2023
First Posted
September 21, 2023
Study Start
June 1, 2023
Primary Completion
July 31, 2024
Study Completion
December 31, 2024
Last Updated
September 21, 2023
Record last verified: 2023-09
Data Sharing
- IPD Sharing
- Will not share